Companies: 10,795·Total market cap: $144.5T
Life Stem Genetics Inc.

Life Stem Genetics Inc.

LIFSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4584
P/E Ratio
52W High$0.0003
52W Low$0.0001
Overview

Life Stem Genetics Inc.(LIFS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LIFS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-06
Revenue
Revenue$0.00B$0.00B
Cost of Revenue$0.00B$0.00B
Gross Profit$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.00B$0.00B
G&A Expenses$0.00B$0.00B
Total Operating Expenses$0.00B$0.00B
Operating Income($0.00B)($0.00B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B
Interest Expense$0.00B$0.00B
Income Before Tax($0.00B)($0.00B)
Income Tax Expense$0.00B$0.00B
Net Income($0.00B)($0.00B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$0.00$-0.00
Wtd Avg Shares0.25B0.25B
EBITDA($0.00B)($0.00B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Life Stem Genetics Inc.

关于Life Stem Genetics Inc.(LIFS)损益表

Life Stem Genetics Inc.(LIFS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LIFS实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.00B)(净利率—)。

常见问题

LIFS · 4 问

Life Stem Genetics Inc.(LIFS)2025财年营收为$0.00B,同比down—%。

LIFS revenueLIFS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08